PCVX vs STE
Vaxcyte, Inc. vs Steris — AI-powered side-by-side comparison
PCVX
Vaxcyte, Inc.
64
Buy
VS
| Metric | PCVX | STE |
|---|
| AI Score |
64
|
54
|
| Price |
$62.59
|
$237.96
|
| P/E Ratio |
-8.20×
|
29.02×
|
| ROE |
-28.5%
|
10.9%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
0.0%
|
44.4%
|
| Debt / Equity |
0.04×
|
0.28×
|
| Dividend Yield |
0.0%
|
1.1%
|
| RSI (14) |
65.9
|
62.9
|
| Beta |
1.21
|
0.914
|
| Expected Upside |
+0.9%
|
+6.2%
|
AI Committee View
Current Innellis committee reasoning for PCVX versus STE.
PCVX leads by 10 points.
PCVX scores 64/100 (Buy) versus STE at 54/100 (Watch).
PCVX Committee View
50% agreement
6 analysts
The committee is split. Analysts see this stock differently enough that the current rating reflects genuine uncertainty, not a weak signal.
Bull Case
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- ROE of only -37.6% -- cheap may mean cheap for a reason — Value
- Bollinger bandwidth of 20.8% signals elevated volatility — Risk
STE Committee View
50% agreement
4 analysts
The committee is genuinely divided. News Analyst sees a compelling case — news sentiment is positive (+0.33 across 9 articles, 14d). Growth Analyst remains cautious — growth rate is decelerating quarter over quarter -- the trend line matters more than the level. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- News sentiment is positive (+0.33 across 9 articles, 14d) — News
Bear Case
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
- MACD histogram negative -- bearish momentum — Technical